• 6476
    Citations
1997 …2024

Research activity per year

Filter
Chapter

Search results

  • 2018

    Ponatinib: A third-generation inhibitor for the treatment of CML

    Wehrle, J. & von Bubnoff, N., 2018, Recent Results in Cancer Research. Springer New York LLC, p. 109-118 10 p. (Recent Results in Cancer Research; vol. 212).

    Research output: Chapters in Books/Reports/Conference ProceedingsChapterpeer-review

    5 Citations (Scopus)
  • Ruxolitinib

    Ajayi, S., Becker, H., Reinhardt, H., Engelhardt, M., Zeiser, R., von Bubnoff, N. & Wäsch, R., 2018, Recent Results in Cancer Research. Springer New York LLC, p. 119-132 14 p. (Recent Results in Cancer Research; vol. 212).

    Research output: Chapters in Books/Reports/Conference ProceedingsChapterpeer-review

    19 Citations (Scopus)